Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: National Health Investors Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
National Health Investors Inc. May 21, 202553.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | National Health Investors Inc. | Gift | −225 | — | — |
| Mar 3, 2026 | National Health Investors Inc. | Grant or award | +1,268 | — | — |
| Feb 17, 2026 | National Health Investors Inc. | Option exercise | +10,000 | $73.34 | $733,400 |
| Feb 17, 2026 | National Health Investors Inc. | Shares withheld for tax | −8,058 | $91.02 | $733,439 |
| Nov 20, 2025 | National Health Investors Inc. | Option exercise | +25,000 | $69.20 | $1,730,000 |
| Nov 20, 2025 | National Health Investors Inc. | Shares withheld for tax | −22,135 | $78.16 | $1,730,072 |
| Aug 23, 2024 | National Health Investors Inc. | Option exercise | +25,000 | $53.41 | $1,335,250 |
| Aug 23, 2024 | National Health Investors Inc. | Option exercise | +10,000 | $54.73 | $547,300 |
| Aug 23, 2024 | National Health Investors Inc. | Option exercise | +10,000 | $57.76 | $577,600 |
| Aug 23, 2024 | National Health Investors Inc. | Shares withheld for tax | −31,289 | $78.63 | $2,460,254 |
| Aug 30, 2023 | National Health Investors Inc. | Open-market purchase | +1,000 | $51.40 | $51,400 |
Questions about James R. Jobe
What boards is James R. Jobe on?
James R. Jobe sits on the board of National Health Investors Inc.
How long has James R. Jobe served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.